Found: 10
Select item for more details and to access through your institution.
Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 7, p. 3087, doi. 10.1007/s12325-023-02497-y
- By:
- Publication type:
- Article
Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Treatments for Non-Transplant Eligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Matching-Adjusted Indirect Comparison.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2668, doi. 10.1007/s12325-022-02094-5
- By:
- Publication type:
- Article
Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study.
- Published in:
- Hematology Reports, 2024, v. 16, n. 2, p. 283, doi. 10.3390/hematolrep16020028
- By:
- Publication type:
- Article
Effect of Heterogeneous Mixing and Vaccination on the Dynamics of Anthelmintic Resistance: A Nested Model.
- Published in:
- PLoS ONE, 2010, v. 5, n. 5, p. 1, doi. 10.1371/journal.pone.0010686
- By:
- Publication type:
- Article
Burden of hospitalizations and outpatient visits associated with moderate and severe acute graft-versus-host disease in Finland and Sweden: a real-world data study.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 6, p. 5125, doi. 10.1007/s00520-022-06915-9
- By:
- Publication type:
- Article
PHASE TRANSITIONS, MEMORY AND FRUSTRATION IN A SZNAJD-LIKE MODEL WITH SYNCHRONOUS UPDATING.
- Published in:
- International Journal of Modern Physics C: Computational Physics & Physical Computation, 2003, v. 14, n. 9, p. 1223, doi. 10.1142/S0129183103005352
- By:
- Publication type:
- Article
Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
- Published in:
- Annals of Hematology, 2023, v. 102, n. 7, p. 1773, doi. 10.1007/s00277-023-05196-4
- By:
- Publication type:
- Article
Correction: Relationship between the Uncompensated Price Elasticity and the Income Elasticity of Demand under Conditions of Additive Preferences.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Relationship between the Uncompensated Price Elasticity and the Income Elasticity of Demand under Conditions of Additive Preferences.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0151390
- By:
- Publication type:
- Article